Loading clinical trials...
Loading clinical trials...
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating pa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT02688894 · Small Cell Lung Cancers, Neuroendocrine Carcinoma
NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT04475640 · Breast Carcinoma, Carcinoma of Unknown Primary, and more
NCT05691465 · Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma, and more
Memorial Sloan-Kettering Cancer Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions